Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vital Living

This article was originally published in The Tan Sheet

Executive Summary

Third-quarter revenues increased 47% to $1.5 mil. and net loss decreased 99.5% to $11,000, Vital Living announces Nov. 3. As gross profit rose 70% to $853,000, CEO Stuart Bensons attributed the company's "substantially improved financial results" to the "corporate turnaround" program that was initiated last year. "The compay's ability to execute successfully its business plan by focusing on its core competencies led to a dramatic improvement in the bottom line, as we approached breakeven in the third quarter," Benson added. Strong revenue growth "resulted primarily from increased sales of our core product, GreensFirst, combined with the positive momentum achieved in our extended Doctors for Nutrition brand," CFO Gregg Linn said. Vital Living intends to expand its regional distributor base as well as introduce a proprietary quality-assurance program called Vital Assure...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098811

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel